SEC Form 4 · accession 0000905718-18-000324
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome D Jabbour
Officer — Chief Executive Officer · Director
Period of report
Mar 22, 2018
Accepted (ET)
Mar 23, 2018 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $0.98 | Mar 22, 2018 | A | 1,000,000 | A | — | Mar 21, 2028 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F125% of the shares vest on March 22, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.
- F2Since the date of the reporting person's last ownership report, he transferred 379,687 shares of issuer's common stock to his ex-wife pursuant to a domestic relations order and he transferred the economic benefits of employee stock options to purchase an aggregate of 612,500 shares with exercise prices ranging from $0.41 to $1.28 per share to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife.